Home > Annual Financials > MEDICO REMEDIES

MEDICO REMEDIES Financial Statement Analysis
[BOM: 540937|NSE : MEDICO]

The Revenues of MEDICO REMEDIES have increased by 4.15% YoY .
The Earnings Per Share (EPS) of MEDICO REMEDIES has increased by 22.00 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

MEDICO REMEDIES Last 5 Annual Financial Results
[BOM: 540937|NSE : MEDICO]

StandaloneMar2025
Mar2024
Mar2023
Mar2022
Mar2021
Revenues ₹151 Cr₹145 Cr₹140 Cr₹121 Cr₹122 Cr
Expenses ₹137 Cr₹132 Cr₹131 Cr₹114 Cr₹117 Cr
Operating Profit (Excl OI) ₹14 Cr₹13 Cr₹9.48 Cr₹7.34 Cr₹5.24 Cr
Other Income ₹3.27 Cr₹2.13 Cr₹4.09 Cr₹2.03 Cr₹1.03 Cr
Interest ₹1.16 Cr₹0.82 Cr₹0.75 Cr₹0.66 Cr₹0.92 Cr
Depreciation ₹3.03 Cr₹2.88 Cr₹2.72 Cr₹2.22 Cr₹1.65 Cr
Profit Before Tax ₹14 Cr₹11 Cr₹10 Cr₹6.48 Cr₹3.70 Cr
Profit After Tax ₹10 Cr₹8.29 Cr₹7.24 Cr₹4.81 Cr₹2.59 Cr
Earnings Per Share (Rs)₹1.22₹1.00₹0.87₹2.90₹6.24
PAT Margin (%)6.695.725.163.982.12
ROE(%)17.5817.2318.0113.948.31
ROCE(%)21.6521.9021.8815.0910.13
Total Debt/Equity(x)0.220.130.180.290.46

Key Financials

Market Cap : ₹ 414.5 Cr
Revenue (TTM) : ₹ 158.4 Cr
Net Profit(TTM) : ₹ 10.3 Cr
EPS (TTM) : ₹ 1.2
P/E (TTM) : 40.1

Industry Peers & Returns1W1M1Y
MEDICO REMEDIES 1.4% 8.5% -2.6%
SUN PHARMACEUTICAL INDUSTRIES 1.2% 4.2% -10.9%
DIVIS LABORATORIES -0.5% 8.9% 10.8%
CIPLA 0.4% 3.7% 8%
TORRENT PHARMACEUTICALS -0% -2.1% 6.6%
DR REDDYS LABORATORIES 2.2% -1.8% -4.4%
MANKIND PHARMA -1.9% -5.1% -7.3%
ZYDUS LIFESCIENCES 1.9% -3.8% 0.3%
LUPIN -0.4% -3.7% -9.7%


MEDICO REMEDIES Revenues
[BOM: 540937|NSE : MEDICO]

Y-o-Y

4.15 %

5 Yr CAGR

5.38 %

Years Revenues % Change
Mar2025 ₹151 Cr
4.15
Mar2024 ₹145 Cr
3.19
Mar2023 ₹140 Cr
16.04
Mar2022 ₹121 Cr
-1.12
Mar2021 ₹122 Cr -


MEDICO REMEDIES Operating Profit
[BOM: 540937|NSE : MEDICO]

Y-o-Y

11.71 %

5 Yr CAGR

28.80 %

Years Operating Profit % Change
Mar2025 ₹14 Cr
11.71
Mar2024 ₹13 Cr
36.16
Mar2023 ₹9.48 Cr
29.26
Mar2022 ₹7.34 Cr
39.98
Mar2021 ₹5.24 Cr -

Operating Margins
Y-o-Y

7.18 %

5 Yr CAGR

22.22 %

Years Operating Margin% % Change
Mar2025 9.55%
7.18
Mar2024 8.91%
32.00
Mar2023 6.75%
11.39
Mar2022 6.06%
41.59
Mar2021 4.28% -

MEDICO REMEDIES Profit After Tax
[BOM: 540937|NSE : MEDICO]

Y-o-Y

21.73 %

5 Yr CAGR

40.50 %

Years Profit After Tax % Change
Mar2025 ₹10 Cr
21.73
Mar2024 ₹8.29 Cr
14.48
Mar2023 ₹7.24 Cr
50.50
Mar2022 ₹4.81 Cr
85.79
Mar2021 ₹2.59 Cr -

PAT Margins
Y-o-Y

16.96 %

5 Yr CAGR

33.28 %

Years PAT Margin(%) % Change
Mar2025 6.69 %
16.96
Mar2024 5.72 %
10.85
Mar2023 5.16 %
29.65
Mar2022 3.98 %
87.74
Mar2021 2.12 % -

MEDICO REMEDIES Earnings Per Share (EPS)
[BOM: 540937|NSE : MEDICO]

Y-o-Y

22.00 %

5 Yr CAGR

-33.50 %

Years EPS % Change
Mar2025 ₹1.22
22.00
Mar2024 ₹1.00
14.94
Mar2023 ₹0.87
-70.00
Mar2022 ₹2.90
-53.53
Mar2021 ₹6.24 -

MEDICO REMEDIES Return on Capital Employed (ROCE)
[BOM: 540937|NSE : MEDICO]

Y-o-Y

-1.14 %

5 Yr CAGR

20.91 %

Years ROCE % Change
Mar2025 21.65%
-1.14
Mar2024 21.9%
0.09
Mar2023 21.88%
45.00
Mar2022 15.09%
48.96
Mar2021 10.13% -

MEDICO REMEDIES Share Price vs Sensex

Current Share Price : ₹49.9
Current MarketCap: ₹ 414.5 Cr
Updated EOD on :Oct 24,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICO REMEDIES

1.4%

8.5%

-2.6%

SENSEX

0.9%

2.5%

3.7%

MEDICO REMEDIES related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about MEDICO REMEDIES Financials


How the annual revenues of MEDICO REMEDIES have changed ?

The Revenues of MEDICO REMEDIES have increased by 4.15% YoY .

How the Earnings per Share (EPS) of MEDICO REMEDIES have changed?

The Earnings Per Share (EPS) of MEDICO REMEDIES has increased by 22.00 % YoY .